Thinking of joining a study?

Register your interest

NCT05558046 | Not yet recruiting | DNA Damage


Predictive Value of Granulosa Cell DNA Damage in the Success of Assisted Reproductive Technique
Sponsor:

Zeynep Kamil Maternity and Pediatric Research and Training Hospital

Information provided by (Responsible Party):

Erman Çiftçi

Brief Summary:

Deoxyribonucleic acid (DNA) damage of granulosa cells obtained during oocyte retrieval will be evaluated by flow cytometry with detection of Histone H2A.X and Phosphorylated Gamma H2A.X protein levels in patients with low ovarian reserve and unexplained infertile patients as a control group undergoing intracytoplasmic sperm injection (ICSI) treatment. Fertilization, embryo quality, transfer rate, implantation, clinical pregnancy will be recorded as well as demographic data. DNA damage of granulosa cells will be compared between two groups. The effect of DNA damage of granulosa cells on fertilization, quality of oocyte and embryo, implantation, and clinical pregnancy will be also evaluated.

Condition or disease

DNA Damage

Granulosa Cells

Detailed Description:

Granulosa cells surrounding the oocytes will be mechanically obtained during the oocyte pick-up procedure in women undergoing intracytoplasmic sperm injection (ICSI) treatment due to unexplained infertility and low ovarian reserve. Deoxyribonucleic acid (DNA) damage in these cells will be evaluated by flow cytometry. Fertilization rates, embryo quality by grading, and transfer rates will also be assessed. Implantation and clinical pregnancy rates will be recorded as well as demographic data such as age, body-mass index, smoking, alcohol use, employment, coexisting chronic disease, infertility duration, etiology of infertility, treatment protocol. Implantation will be evaluated by determination of serum human chorionic gonadotropin (hCG) at day 15 following an embryo transfer. Clinical pregnancy will be diagnosed upon presence of gestational sac on ultrasound examination. DNA damage of granulosa cells will be compared between low ovarian reserve group and control group. The effect of DNA damage of granulosa cells on fertilization, quality of oocyte and embryo, implantation, and clinical pregnancy will be also evaluated.}}

Study Type : Observational
Estimated Enrollment : 60 participants
Official Title : Predictive Value of Granulosa Cell DNA Damage in the Success of Assisted Reproductive Technique
Actual Study Start Date : October 1, 2022
Estimated Primary Completion Date : March 1, 2023
Estimated Study Completion Date : June 20, 2023

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years to 35 Years
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: Accepts Healthy Volunteers
Criteria
Inclusion Criteria
  • For patients who are undergoing in Vitro Fertilization (IVF) treatment with Low ovarian reserve, Antimullerian Hormone level must be lower than 1 ng/mL
  • For patients who are undergoing in Vitro Fertilization (IVF) treatment with Unexplained infetility, Antimullerian Hormone level must be greater than 1,5 ng/mL
Exclusion Criteria
  • Chronic systemic disease (rheumatoid arthritis, hypertension, diabetes..)
  • Endocrinopathy (Thyroid, prolactin... abnormalities)
  • Chemotherapy or radiotherapy history
  • Endometriosis
  • Policystic ovary syndrome
  • Male infetility

Predictive Value of Granulosa Cell DNA Damage in the Success of Assisted Reproductive Technique

Location Details


Please Choose a site



Predictive Value of Granulosa Cell DNA Damage in the Success of Assisted Reproductive Technique

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Loading...